Dashboard
Manage Tickers

ZIMVZimVie Inc.

Nasdaq zimvie.com


$ 15.66 $ -0.15 (-0.95 %)    

Monday, 29-Apr-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 15.67
$ 15.76
$ 0.00 x 0
$ 0.00 x 0
$ 15.62 - $ 16.05
$ 6.52 - $ 20.91
153,571
na
424.4M
$ 1.40
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-31-2023 10-K
2 11-01-2023 09-30-2023 10-Q
3 08-02-2023 06-30-2023 10-Q
4 05-03-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-10-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

needham-reiterates-hold-on-zimvie
Needham Reiterates Hold on ZimVie
04/11/2024 09:49:07

Needham analyst David Saxon reiterates ZimVie (NASDAQ:ZIMV) with a Hold.

micron-iris-energy-tripcom-group-and-other-big-stocks-moving-higher-on-monday
Micron, Iris Energy, Trip.com Group And Ot...
04/01/2024 17:02:28

U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday.

zimvie-expects-to-achieve-an-annualized-financial-profile-of-455m-in-net-sales-vs-45405m-est-a-15-adjusted-ebitda-margin-1-year-following-the-close-of-the-deal
ZimVie Expects To Achieve An Annualized Fi...
04/01/2024 13:37:47

Outlook for ZimVieAs previously communicated, ZimVie expects to achieve an annualized financial profile of $455+ million in Net...

zimvie-announces-closing-of-sale-of-spine-business-to-an-affiliate-of-hig-capital-for-375m-in-total-consideration
ZimVie Announces Closing Of Sale Of Spine ...
04/01/2024 13:36:12

ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced that it has closed the previousl...

barclays-maintains-underweight-on-zimvie-raises-price-target-to-16
Barclays Maintains Underweight on ZimVie, ...
03/05/2024 11:44:45

Barclays analyst Matt Miksic maintains ZimVie (NASDAQ:ZIMV) with a Underweight and raises the price target from $13 to $16.

zimvie-expects-q1-net-sales-continuing-operations-of-115m-118m-discontinued-operations-of-89m-91m
ZimVie Expects Q1 Net Sales: Continuing Op...
02/28/2024 22:00:50

Management raises financial targets for continuing operations for the 12 month period post-spine sale: Net Sales $455M+, Adjust...

recap-zimvie-q4-earnings
Recap: ZimVie Q4 Earnings
02/28/2024 21:45:20

zimvie-q4-2023-adj-eps-010-misses-012-estimate-sales-11307m-miss-21345m-estimate
ZimVie Q4 2023 Adj EPS $0.10 Misses $0.12 ...
02/28/2024 21:41:31

ZimVie (NASDAQ:ZIMV) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.12 by 16....

earnings-scheduled-for-february-28-2024
Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

a-preview-of-zimvies-earnings
A Preview Of ZimVie's Earnings
02/27/2024 20:01:37

barclays-maintains-underweight-on-zimvie-raises-price-target-to-13
Barclays Maintains Underweight on ZimVie, ...
01/04/2024 13:24:32

Barclays analyst Matt Miksic maintains ZimVie (NASDAQ:ZIMV) with a Underweight and raises the price target from $11 to $13.

jp-morgan-maintains-neutral-on-zimvie-raises-price-target-to-16
JP Morgan Maintains Neutral on ZimVie, Rai...
12/20/2023 20:27:02

JP Morgan analyst Robbie Marcus maintains ZimVie (NASDAQ:ZIMV) with a Neutral and raises the price target from $10 to $16.

fear--greed-index-remains-in-extreme-greed-zone-sp-500-settles-higher
Fear & Greed Index Remains In 'Extreme Gre...
12/19/2023 08:34:51

The CNN Money Fear and Greed index showed some easing in overall market sentiment, but the index remained in the "Extreme G...

nasdaq-gains-100-points-biomerica-shares-spike-higher
Nasdaq Gains 100 Points; Biomerica Shares ...
12/18/2023 19:21:38

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The D...

why-lantheus-holdings-shares-are-trading-lower-by-over-22-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Lantheus Holdings Shares Are Trading L...
12/18/2023 18:05:04

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma ann...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
12/18/2023 17:32:13

crude-oil-rises-3-us-housing-market-index-increases-in-december
Crude Oil Rises 3%; US Housing Market Inde...
12/18/2023 17:17:23

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded ...

zimvie-agrees-to-sell-its-spine-business-joins-united-states-steel-pgt-innovations-and-other-big-stocks-moving-higher-on-monday
ZimVie Agrees To Sell Its Spine Business, ...
12/18/2023 15:57:14

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 30 points on Monday.

why-surgical-and-medical-instrument-manufacturing-company-zimvie-shares-are-rocketing-today
Why Surgical And Medical Instrument Manufa...
12/18/2023 14:37:02

ZimVie Inc (NASDAQ: ZIMV) shares are trading higher by over 33% after the company disclosed an agreement to sell its spine busi...

zimvie-agrees-to-sell-its-spine-business-to-hig-capital-for-375m
ZimVie Agrees To Sell Its Spine Business T...
12/18/2023 13:02:08

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION